EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement

Marco Frigeni, Alessandra Algarotti, Silvia Salmoiraghi, Clara Belotti, Martina Milani, Chiara Pavoni, Orietta Spinelli, Irene Gotuzzo, Alessandro Rambaldi, Federico Lussana

Annals of Hematology · 10.04.2026 · 105 (5)

DOI: 10.1007/s00277-026-06953-x ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, online erschienen am 10.04.2026. Verfasst von Marco Frigeni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Piazza OMS, 1, Bergamo, 24127, Italy. mfrigeni@asst-pg23.it. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Proto-Oncogene Proteins c-kit, Hematopoietic Stem Cell Transplantation, Pyrazoles. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteProto-Oncogene Proteins c-kitHematopoietic Stem Cell TransplantationPyrazolesPyrrolesMutationCentral Nervous System NeoplasmsHumansAvapritinibMaleMiddle AgedTransplantation, HomologousRecurrence

Substanzen

AvapritinibProto-Oncogene Proteins c-kitPyrazolesPyrrolesKIT protein, human

Autor:innen und Institutionen

  • Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Piazza OMS, 1, Bergamo, 24127, Italy. mfrigeni@asst-pg23.it.
  • Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Piazza OMS, 1, Bergamo, 24127, Italy.
  • FROM Research Foundation, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Nuclear Medicine Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Department of Oncology and Hematology, University of Milan, Milano, Italy.

Zitieren

APA

Frigeni, M., Algarotti, A., Salmoiraghi, S., Belotti, C., Milani, M., Pavoni, C., Spinelli, O., Gotuzzo, I., Rambaldi, A., & Lussana, F. (2026). Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement. Annals of Hematology, 105(5). https://doi.org/10.1007/s00277-026-06953-x

Vancouver

Frigeni M, Algarotti A, Salmoiraghi S, Belotti C, Milani M, Pavoni C, et al. Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement. Annals of Hematology. 2026;105(5). doi:10.1007/s00277-026-06953-x

BibTeX
@article{Frigeni2026,
  author = {Frigeni, Marco and Algarotti, Alessandra and Salmoiraghi, Silvia and Belotti, Clara and Milani, Martina and Pavoni, Chiara and Spinelli, Orietta and Gotuzzo, Irene and Rambaldi, Alessandro and Lussana, Federico},
  title = {Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {5},
  doi = {10.1007/s00277-026-06953-x}
}
Kostenlos starten →